It is one of GSK's top drugs, with sales of $2.2 billion last year, jostling for market share with other IL-5 inhibitors, notably AstraZeneca's Fasenra (benralizumab) – dosed every four weeks ...

More than 50% of patients with severe asthma have high eosinophil levels, making them candidates for biologic therapies like Nucala and other drugs like AstraZeneca’s Fasenra (benralizumab ...

Emphysematous changes refer to changes that may occur in the lungs as emphysema progresses and are visible on a CT scan. This may include changes in location or the type of damage in the lungs due ...

Roshni Naik, MD, allergist at Mount Sinai Health System, discusses the history of present illness for a case of severe asthma with nasal polyps: "Patient is a 45 year-old male with a past medical ...

Share price of Indo Count Industries tanked 17 per cent at ₹241.10 on the BSE in Monday’s intra-day trade after the company reported a sharp 88 per cent decline in its consolidated profit after tax ...

The Asthma Market was valued at approximately USD 25 Billion in 2023 and is expected to grow at a strong CAGR of around ~5% during the forecast period (2024-2032) owing to the robust pipeline activity ...

Ucal Limited formerly known as 'UCAL Fuel Systems Limited' was incorporated on November 4 1985 which changed to 'Ucal Limited' on April 6 2023. The Company is among the the leading Companies in Fuel ...